Bath & Body Works Inc. (BBWI)

NYSE


	Symbol		Exchange		Currency
	BBWI		NYSE		USD	Real-time
	LTD0		TradeGate		EUR	Delayed
	LTD0		Frankfurt		EUR	Delayed
	BBWI		Vienna		EUR	Real-time

Currency in USD

Disclaimer

29.92

+0.35(+1.18%)

Closed04/10

After Hours

30.23+0.31(+1.04%)

05/10

Fair Value

Day's Range

29.62

30.87

52 wk Range

26.21

52.99

BBWI Income Statement

Featured here, the Income Statement (earnings report) for Bath & Body Works Inc., showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/01

2016

30/01

2017

28/01

2018

03/02

2019

02/02

2020

01/02

2021

30/01

2022

29/01

2023

28/01

2024

03/02

Total Revenues

5,405

6,434

7,882

7,560

7,429

Total Revenues Growth

-59.17%

+19.04%

+22.51%

-4.09%

-1.73%

Cost Of Revenues

2,755

3,084

4,027

4,305

4,193

Gross Profit

2,650

3,350

3,855

3,255

3,236

Gross Profit Growth

-53.91%

+26.42%

+15.07%

-15.56%

-0.58%

Gross Profit Margin %

49.03%

52.07%

48.91%

43.06%

43.56%

Other Operating Expenses, Total

597

1,492

1,846

1,879

1,951

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-86.08%	+149.92%	+23.73%	+1.79%	+3.83%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	597	1,492	1,846	1,879	1,951
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

2,053

1,858

2,009

1,376

1,285

Operating Income Growth

+40.62%

-9.5%

+8.13%

-31.51%

-6.61%

EBIT Margin %

37.98%

28.88%

25.49%

18.2%

17.3%

Net Interest Expenses

-370

-432

-388

-331

-290

Net Interest Expenses Growth

+3.9%

-16.76%

+10.19%

+14.69%

+12.39%

Interest Expense, Total

-370

-432

-388

-348

-345

Interest And Investment Income

-

-

-

17

55

Other Non Operating Expenses, Total

15

3

-3

-

-

EBT, Excl. Unusual Items

1,698

1,429

1,618

1,045

995

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-303

-307

-195

-

34

EBT, Incl. Unusual Items

608

1,122

1,423

1,045

1,021

EBT, Incl. Unusual Items Growth

-29.05%

+84.54%

+26.83%

-26.56%

-2.3%

EBT, Incl. Unusual Items Margin

11.25

17.44

18.05

13.82

13.74

Income Tax Expense

148

257

348

251

143

Net Income to Company

-366

844

1,333

800

878

Minority Interest

-

-

-

-

-

Net Income

-366

844

1,333

800

878

Net Income Growth

-156.83%

+330.6%

+57.94%

-39.98%

+9.75%

Net Income Margin %

-6.77%

13.12%

16.91%

10.58%

11.82%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

460

865

1,075

794

878

Basic EPS - Continuing Operations

1.67

3.11

4

3.42

3.85

Basic EPS - Continuing Operations Growth

-28.57%

+86.69%

+28.44%

-14.36%

+12.52%

Diluted EPS - Continuing Operations

1.65

3.07

3.94

3.4

3.84

Diluted EPS - Continuing Operations Growth

-28.57%

+86.06%

+28.34%

-13.71%

+12.94%

Basic Weighted Average Shares Outstanding

276

278

269

232

228

Diluted Weighted Average Shares Outstanding

278

281

273

233

229

Dividend Per Share

1.2

0.3

0.45

0.8

0.8

Dividend Per Share Growth

-50%

-75%

+50%

+77.78%

0%

EBITDA

2,641

2,053

2,214

1,597

1,554

EBITDA Growth

+28.83%

-22.26%

+7.84%

-27.87%

-2.69%

EBITDA Margin %

48.86%

31.91%

28.09%

21.12%

20.92%

EBIT